Trainline Shares Rally as Company Raises FullYear Guidance for Second Time in Fiscal 2026 Geopolitical Tensions Escalate as Putin Vows Retaliation Over Ukraine Strike Claims TPA and NCPA Hail Tennessee Law Restricting Pharmacy Benefit Manager Ownership of Pharmacies Micron Technology Shares Rise Following UBS Price Target Increase on Strong Memory Demand Oregons Gas Tax Defeat Political Fallout and Implications for Infrastructure Funding Nios LongTerm Growth Potential Possibility of Doubling by 2029 GNS Q4 2022 Earnings EPS Falls Short of Estimates Stock Surges 2278 MTDR Q1 2026 Earnings Strong Earnings Beat Offsets Market Caution Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues LGCY Q1 2026 Earnings EPS Beats Estimates by 244 Revenue Not Disclosed CWT Q1 2026 Earnings Earnings Miss Amidst Operational Challenges Stock Still Rises MVIS Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Stock Rises Butterfly Network BFLY Gains 3 as Shares Approach Key Resistance Level UnitedGuardian Inc UG Slides 113 as Stock Tests Key Support Zone United Therapeutics UTHR Holds Steady Near 568 as Key Levels Come into Focus BRP Inc DOO Gains Ground as Shares Approach Key Resistance Level Gold Resource Corporation GORO Surges on Bullish Momentum Eyes Resistance at 144 Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives TSAT Q1 2026 Earnings Massive EPS Miss Overshadows Missing Revenue as Stock Edges Higher EPower Inc EPOW Edges Higher Tests Key Resistance at 070 Quantum Biopharma Ltd QNTM Q4 2025 Earnings Biotech Reports Wider Loss Amid Strategic Progress Stock Jumps 18 APWC Q3 1997 Earnings Missed Estimates Amid Operational Challenges New Concept Energy Inc GBR Q3 2023 Earnings Small Profit Achieved as Stock Moves Higher PAC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Excellence and Traffic Momentum CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition NKSH Q4 2025 Earnings Strong EPS Beat Drives Positive Sentiment AKTS Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Shares Edge Higher